{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:17:47Z","timestamp":1792199867169,"version":"4.4.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evaluate the association of APS and SLE, focusing on LN, with risk of pre-eclampsia (PE) and PE with severity criteria (PESC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analysis of pregnant women admitted between 2016\u20132022, using data from the Spanish Hospital Discharge Database. Factors associated with PE and PESC, including early-onset PE, severe PE, eclampsia and HELLP syndrome were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1\u2009973\u2009249 admissions, 1787 patients had SLE (9.1\u2030), with prior LN in 13.2%. SLE patients experienced higher PE (5.5% vs 2.1%) and PESC (2.1% vs 0.6%) rates; these rose further in SLE women with LN alone (PE: 10.3%, PESC: 4.2%) or with both LN and APS (PE: 22.7%, PESC: 9.1%) . Adjusted analyses showed PE and PESC were each associated with SLE (OR\u2009=\u20091.78, 95% CI 1.39\u20132.28; OR\u2009=\u20092.17, 95% CI 1.47\u20133.22), LN (OR\u2009=\u20091.94, 95% CI 1.18\u20133.19; OR\u2009=\u20092.45, 95% CI 1.18\u20135.09) and APS (OR\u2009=\u20091.53, 95% CI 1.28\u20131.84; OR\u2009=\u20091.91, 95% CI 1.44\u20132.54). Within SLE patients, baseline hypertension (OR\u2009=\u20094.27, 95% CI 2.45\u20137.44), LN (OR\u2009=\u20092.06, 95% CI 1.26\u20133.37) and APS (OR\u2009=\u20091.85, 95% CI 1.03\u20133.32) were linked to PE, while LN alone predicted PESC (OR\u2009=\u20092.88, 95% CI 1.41\u20135.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The risk of PE and PESC that patients with SLE exhibit is further amplified in those with a history of LN or APS. Recognizing SLE, APS and especially LN is crucial for precise risk stratification and tailored management to improve maternal and fetal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf484","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:59:57Z","timestamp":1757591997000},"source":"Crossref","is-referenced-by-count":3,"title":["Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1028-3486","authenticated-orcid":false,"given":"Mario","family":"Mart\u00edn-Portugu\u00e9s","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4671-7143","authenticated-orcid":false,"given":"Jorge","family":"Esteban-Sampedro","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7548-8341","authenticated-orcid":false,"given":"Susana","family":"Mellor-Pita","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-9073","authenticated-orcid":false,"given":"Pablo","family":"Tutor de Ureta","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1n","family":"Fern\u00e1ndez-Guiti\u00e1n","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-7628","authenticated-orcid":false,"given":"Ana","family":"Huerta","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario Puerta de Hierro , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-1043","authenticated-orcid":false,"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"additional","affiliation":[{"name":"Biobizkaia Health Research Institute , , Hospital Universitario Cruces , Bizkaia,","place":["Spain"]},{"name":"Autoimmune Diseases Research Unit , , Hospital Universitario Cruces , Bizkaia,","place":["Spain"]},{"name":"Faculty of Medicine, UPV\/EHU , Leioa,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8256-9353","authenticated-orcid":false,"given":"Luis","family":"Due\u00f1a-Bartolome","sequence":"additional","affiliation":[{"name":"Biobizkaia Health Research Institute , , Hospital Universitario Cruces , Bizkaia,","place":["Spain"]},{"name":"Autoimmune Diseases Research Unit , , Hospital Universitario Cruces , Bizkaia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-081X","authenticated-orcid":false,"given":"Ana","family":"Royuela","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), Biostatistics Unit, Instituto de Investigaci\u00f3n Puerta de Hierro-Segovia de Arana , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9173-8783","authenticated-orcid":false,"given":"Alfonso","family":"Ortega-de la Puente","sequence":"additional","affiliation":[{"name":"Escuela Superior de Ingenier\u00eda y Tecnolog\u00eda, Universidad Internacional de La Rioja , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-5541","authenticated-orcid":false,"given":"Marina","family":"de la Cruz-Echeand\u00eda","sequence":"additional","affiliation":[{"name":"Escuela Superior de Ingenier\u00eda y Tecnolog\u00eda, Universidad Internacional de La Rioja , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-4514","authenticated-orcid":false,"given":"V\u00edctor","family":"Moreno-Torres","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Health Research Institute Puerta de Hierro-Segovia de Arana (IDIPHIM), Hospital Universitario Puerta de Hierro , Madrid, Majadahonda,","place":["Spain"]},{"name":"UNIR Health Sciences School & Medical Center, Universidad Internacional de La Rioja , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2026020205374544500_keaf484-B1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ecl.2024.05.012","article-title":"Update on preeclampsia and hypertensive disorders of pregnancy","volume":"53","author":"Rosenberg","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026020205374544500_keaf484-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145(Suppl 1)","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"2026020205374544500_keaf484-B3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"2026020205374544500_keaf484-B4","doi-asserted-by":"crossref","first-page":"119922","DOI":"10.1016\/j.cca.2024.119922","article-title":"Preeclampsia: a comprehensive review","volume":"563","author":"Ali","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2026020205374544500_keaf484-B5","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"New Engl J Med"},{"key":"2026020205374544500_keaf484-B6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ogc.2019.10.008","article-title":"The placental basis of fetal growth restriction","volume":"47","author":"Zur","year":"2020","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2026020205374544500_keaf484-B7","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.3390\/jcm10245749","article-title":"Trends in hospital admissions and death causes in patients with systemic lupus erythematosus: Spanish National Registry","volume":"10","author":"Moreno-torres","year":"2021","journal-title":"J Clin Med"},{"key":"2026020205374544500_keaf484-B8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(22)01191-6","article-title":"Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2\u2008198\u2008655 pregnancies","volume":"400","author":"Sheikh","year":"2022","journal-title":"Lancet"},{"key":"2026020205374544500_keaf484-B9","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/RHU.0000000000002141","article-title":"Reproductive health in RA, Lupus, and APS","volume":"30","author":"Zucchi","year":"2024","journal-title":"J Clin Rheumatol"},{"key":"2026020205374544500_keaf484-B10","first-page":"2340","article-title":"Immune cells and infectious diseases in preeclampsia susceptibility","volume":"40","author":"Nieves","year":"2024","journal-title":"Can J Cardiol"},{"key":"2026020205374544500_keaf484-B11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/09612033211004716","article-title":"The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus","volume":"30","author":"Bremme","year":"2021","journal-title":"Lupus"},{"key":"2026020205374544500_keaf484-B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026020205374544500_keaf484-B13","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0140-6736(23)02128-1","article-title":"Autoimmune diseases and adverse pregnancy outcomes: an umbrella review","volume":"402(Suppl 1)","author":"Singh","year":"2023","journal-title":"Lancet"},{"key":"2026020205374544500_keaf484-B14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"2026020205374544500_keaf484-B15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10067-019-04823-8","article-title":"Preeclampsia in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis","volume":"39","author":"Dong","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026020205374544500_keaf484-B16","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026020205374544500_keaf484-B17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-022-06496-2","article-title":"Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis","volume":"42","author":"Liu","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026020205374544500_keaf484-B18","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.medcli.2024.05.001","article-title":"Obstetric antiphospholipid syndrome","volume":"163(Suppl 1)","author":"Soto-Peleteiro","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"2026020205374544500_keaf484-B19","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3390\/biomedicines11082298","article-title":"Preeclampsia and the antiphospholipid syndrome","volume":"11","author":"Mayer-Pickel","year":"2023","journal-title":"Biomedicines"},{"key":"2026020205374544500_keaf484-B20","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"2026020205374544500_keaf484-B21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2021.06.006","article-title":"Early-onset preeclampsia\u2014the impact of antiphospholipid antibodies on disease severity","volume":"263","author":"Zemet","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026020205374544500_keaf484-B22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026020205374544500_keaf484-B23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0032-1311827","article-title":"Pathogenesis of the antiphospholipid syndrome","volume":"38","author":"Willis","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"2026020205374544500_keaf484-B24","doi-asserted-by":"crossref","first-page":"102901","DOI":"10.1016\/j.autrev.2021.102901","article-title":"Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis","volume":"20","author":"Walter","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2026020205374544500_keaf484-B25","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2026020205374544500_keaf484-B26","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.medcli.2024.02.010","article-title":"Thrombotic antiphospholipid syndrome: from guidelines to clinical management","volume":"163(Suppl 1)","author":"Paredes-Ruiz","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"2026020205374544500_keaf484-B27","first-page":"2161","article-title":"Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry","volume":"40","author":"Moreno-Torres","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026020205374544500_keaf484-B28","doi-asserted-by":"crossref","first-page":"107089","DOI":"10.1016\/j.ijid.2024.107089","article-title":"Increased incidence and mortality from Listeria monocytogenes infection in Spain","volume":"145","author":"V\u00e1zquez","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2026020205374544500_keaf484-B29","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia","volume":"135","author":"Espinoza","year":"2020","journal-title":"Obstetr Gynecol"},{"key":"2026020205374544500_keaf484-B30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"New Engl J Med"},{"key":"2026020205374544500_keaf484-B31","doi-asserted-by":"crossref","first-page":"103744","DOI":"10.1016\/j.autrev.2025.103744","article-title":"Maternal and fetal outcomes in Latin American SLE pregnancies: a systematic review and meta-analysis","volume":"24","author":"Cajamarca-Baron","year":"2025","journal-title":"Autoimmun Rev"},{"key":"2026020205374544500_keaf484-B32","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2665-9913(24)00160-7","article-title":"Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"6","author":"Wind","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026020205374544500_keaf484-B33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026020205374544500_keaf484-B34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026020205374544500_keaf484-B35","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.3390\/jcm11226822","article-title":"Early prediction of adverse pregnancy outcome in women with systemic lupus erythematosus, antiphospholipid syndrome, or non-criteria obstetric antiphospholipid syndrome","volume":"11","author":"Ba\u00f1os","year":"2022","journal-title":"J Clin Med"},{"key":"2026020205374544500_keaf484-B36","doi-asserted-by":"crossref","first-page":"1479881","DOI":"10.3389\/flupu.2024.1479881","article-title":"Pregnancy planning in lupus and APS patients","volume":"2","author":"Haase","year":"2024","journal-title":"Front Lupus"},{"key":"2026020205374544500_keaf484-B37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/OARRR.S87828","article-title":"Management of systemic lupus erythematosus during pregnancy: challenges and solutions","volume":"9","author":"Knight","year":"2017","journal-title":"Open Access Rheumatol"},{"key":"2026020205374544500_keaf484-B38","doi-asserted-by":"crossref","first-page":"1390783","DOI":"10.3389\/fneph.2024.1390783","article-title":"Lupus nephritis: management challenges during pregnancy","volume":"4","author":"Gholizadeh Ghozloujeh","year":"2024","journal-title":"Front Nephrol"},{"key":"2026020205374544500_keaf484-B39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/annrheumdis-2018-214434","article-title":"Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort","volume":"78","author":"Mendel","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026020205374544500_keaf484-B40","doi-asserted-by":"crossref","first-page":"103376","DOI":"10.1016\/j.autrev.2023.103376","article-title":"The SPROUT study: a survey on current management practice of reproductive aspects in women of childbearing age with systemic autoimmune rheumatic diseases","volume":"22","author":"Chighizola","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026020205374544500_keaf484-B41","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026020205374544500_keaf484-B42","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000714","article-title":"Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study","volume":"9","author":"Tani","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026020205374544500_keaf484-B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf334","article-title":"An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial","author":"Lee","year":"2025","journal-title":"Rheumatology"},{"key":"2026020205374544500_keaf484-B44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transpl"},{"key":"2026020205374544500_keaf484-B45","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard-2023-224197","article-title":"Systemic lupus erythematosus women with lupus nephritis in pregnancy therapeutic challenge (SWITCH): the Systemic Lupus International Collaborating Clinics experience","volume":"82","author":"Lee","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf484\/64263265\/keaf484.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf484\/64263265\/keaf484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf484\/64263265\/keaf484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:38:00Z","timestamp":1770028680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf484\/8253720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf484","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,14]]},"article-number":"keaf484"}}